Difference between revisions of "Lundbeck"

From Powerbase
Jump to: navigation, search
(Lobbying firms)
Line 19: Line 19:
  
 
==Lobbying firms==
 
==Lobbying firms==
*[[Munro and Foster]]<ref> [http://www.prca.org.uk/assets/files/Consultancy%20Register%20Sept-Nov%202014%20pdf(1).pdf Agency Register September to November 2014] ''PRCA'', accessed 27 January 2015 </ref>
+
*[[Munro and Forster]]<ref> [http://www.prca.org.uk/assets/files/Consultancy%20Register%20Sept-Nov%202014%20pdf(1).pdf Agency Register September to November 2014] ''PRCA'', accessed 27 January 2015 </ref>
  
 
===2014===
 
===2014===

Revision as of 17:55, 28 January 2015

H. Lundbeck A/S (commonly known simply as Lundbeck) is a Danish international pharmaceutical company engaged in the research and development, production, marketing, and sale of drugs for the treatment of disorders in the central nervous system (CNS), including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia.[1]

People

Executive management

Board of Directors

Lobbying firms

2014

Drugs

Nalmefene

Contact

H. Lundbeck A/S
Ottiliavej 9 2500 Valby Denmark
Phone +45 3630 1311
Fax: +45 3630 1940
www.lundbeck.com

Notes

  1. About Us, Lundbeck.com.
  2. Agency Register September to November 2014 PRCA, accessed 27 January 2015